Dr. Arya Sharma

24/01/2025

Go to Ain't Got Time (To Wait For Green).

20/09/2024

New Single Out! Appreciate your comments🙏

Listen to Guitar Player Blues by Arya M. Sharma.

14/07/2024

As Chair of the Working Group, I am thrilled to announce the Set of Patient-Centered Outcome Measures for Adults living with Obesity.

Developed in collaboration with patient representatives, physicians, and measurement experts, ICHOM Sets prioritize a core set of outcomes crucial to patients. The role of the Working Group was to identify, evaluate, and recommend the outcomes that matter most to people living with obesity and a standardized way to measure them while balancing clinical feasibility and scientific rigor.

Visit the ICHOM website to learn more about the Set and how it can enhance your journey in value-based healthcare: https://lnkd.in/dV7TibGn

20/06/2024

My new single LEAVING TOWN BLUES drops tomorrow - pre-save now!

Go to Leaving Town Blues.

15/06/2024

Just 100 short of 1000 streams on Spotify 🤘

Listen to Middle Seat Blues by Arya M. Sharma.

24/05/2024

Has the “muscle loss” issue on obesity medication taken up more space than it deserves?

As anyone working in Obesity Medicine knows, concurrent loss of muscle mass is a physiological response to weight loss.

After all, why should the body invest in maintaining muscle mass that it no longer needs to move a lighter body around?

Indeed, muscle mass is a poor correlate for actual muscle function or mobility. Svelte marathon runners, for example, have far less muscle mass than anyone carrying around 200 pounds - yet, we don’t hear them complaining of sarcopenia!

So, while the problem of disproportionate muscle loss, certainly warrants consideration, especially in the frail elderly, or perhaps in South Asians (where sarcopenic obesity is rampant), this topic is unlikely to be of major relevance for the vast majority of people losing weight on obesity medication.

And, with an adequate amount of protein intake and moderate weight-bearing physical activity, this should rarely be an issue of clinical relevance.

Indeed, as far as function and mobility is concerned, it is muscle strength and endurance that matters, not some arbitrary body composition cut offs. It is for this reason, that I have long advocated for functional measures like grip strength to be included in assessments.

It may also be worthwhile noting, that in my years of caring for individuals, who have lost substantial amounts of weight following bariatric surgery, sarcopenia, resulting in functional limitations, has been rather rare, and generally limited to those individuals who had significant problems maintaining adequate protein intake.

I see no reason to suspect that this issue should now be a greater problem or deserve more attention in individuals losing similar amounts of weight on obesity medication.

25/04/2024

My obesity doctor/musician colleague from Dubai sharing his version of the MIDFLE SEAT BLUES 😎

23/04/2024